For most families, private cord blood banking is not worth the cost. Both the American Academy of Pediatrics and the American College of Obstetricians and Gynecologists recommend against routine private storage, citing a lack of evidence to support it. The exception: families with a child or close relative who has a specific disease treatable with a stem cell transplant. For everyone else, donating to a public bank offers more real-world value.
That said, the decision is rarely simple. Understanding what cord blood actually does, how likely your family is to use it, and what the alternatives look like can help you make a confident choice rather than one driven by marketing.
What Cord Blood Is Used For
Cord blood is rich in blood-forming stem cells, the same type found in bone marrow. These cells can rebuild a patient’s blood and immune system after it has been destroyed by chemotherapy or radiation. The current indications for cord blood transplantation are limited to select genetic, blood, and cancerous disorders, including leukemia, lymphoma, sickle cell disease, and certain immune deficiencies.
One notable advantage of cord blood over traditional bone marrow donation is a lower risk of chronic graft-versus-host disease, a serious complication where the transplanted cells attack the recipient’s body. This reduced risk is significant enough that some transplant specialists consider it the primary reason to favor cord blood as a graft source when a match is available.
Cord blood has also been studied for regenerative medicine applications like cerebral palsy. A 2025 meta-analysis in the journal Pediatrics, pooling data from over 600 children treated across multiple clinical trials, found clinically meaningful improvements in gross motor function for children with cerebral palsy who received cord blood. However, this work has not yet reached the stage of regulatory approval, and researchers emphasize the need for a definitive phase 3 trial. There is no current evidence supporting the use of a person’s own stored cord blood for regenerative medicine.
The Core Problem With Private Banking
Private cord blood banks market stored cord blood as “biological insurance” for your child’s future. The logic sounds appealing: if your child ever needs a stem cell transplant, a perfectly matched unit is waiting in a freezer. In practice, this scenario almost never plays out as advertised.
The most important limitation is that a child’s own cord blood usually cannot treat the very diseases cord blood is used for. If a child develops leukemia, for instance, those same pre-cancerous cells are already present in the stored cord blood. The same is true for genetic diseases. ACOG states plainly that cord blood collected from a newborn cannot be used to treat a genetic disease or malignancy in that same individual because the stored sample contains the same genetic variants or premalignant cells that caused the condition.
This means the primary selling point of private banking, protecting your child with their own cells, doesn’t hold up for the most common transplant scenarios. The stored unit could potentially be used for a sibling, but only if the sibling is a match and has a condition treatable with cord blood transplantation.
Cell Count Limits for Adults
A single cord blood unit contains a limited number of stem cells. This is typically enough for a child’s transplant, but the cell count tends to be too low for an adult recipient. So even if your stored unit were medically appropriate years later, your now-grown child may need more cells than the sample provides. Research into expanding cord blood cells in the lab is underway, but this remains an emerging technique rather than standard practice.
What It Costs
Private cord blood banking involves two costs: an upfront collection and processing fee, typically $1,300 to $2,200, plus an annual storage fee of $125 to $300. Over 18 years, that adds up to roughly $3,500 to $7,600 in storage fees alone, bringing the total to somewhere between $5,000 and $10,000 per child.
For a family without a known medical need, this is a significant expense for a service with an extremely low probability of use. Estimates of the likelihood that a privately banked cord blood unit will ever be used for transplantation vary, but they are consistently very small, on the order of fractions of a percent.
When Private Banking Makes Sense
There is one clear scenario where private banking is worth considering: when you already have a family member, typically an older sibling, with a condition that could benefit from a cord blood transplant. In this case, the new baby’s cord blood may provide a matched or partially matched graft source for the sick child. ACOG specifically endorses private banking in this situation.
Some families with a strong history of blood cancers or genetic disorders treatable with stem cell transplants may also find the investment reasonable, though this is a conversation to have with a genetic counselor or hematologist who knows your family’s specific medical history.
Public Banking as an Alternative
Public cord blood banks collect, test, and store donated cord blood at no cost to the family. The donated unit becomes available to any patient worldwide who needs a transplant and is a tissue match. Public donation is the method recommended by both ACOG and the AAP for obtaining cord blood for transplantation.
The tradeoff is straightforward: you give up exclusive access to your baby’s cord blood in exchange for contributing to a public registry that saves lives. If your child or a family member ever needs a transplant, registries will search for the best available match from all sources, which could include your donated unit if it hasn’t already been used. In most cases, a suitable match can be found through public banks or bone marrow registries regardless of whether you banked privately.
Not every hospital participates in public cord blood collection, so you’ll need to check availability at your delivery hospital. The number of public collection sites remains limited.
Delayed Cord Clamping Compatibility
Many parents planning to bank cord blood also want delayed cord clamping, which delivers more blood and iron to the newborn and is now standard practice. These two goals compete for the same blood supply, which raises a practical concern.
The impact is real but moderate. Following ACOG’s recommended 30 to 60 second delay reduces the collected cord blood volume by roughly 10%. One study of 2,000 collections found that delaying for a minute or more decreased total volume by 6% to 21% and reduced the white blood cell count by 9% to 31%. A shorter delay preserves more of the sample, but a significantly reduced cell count could make the unit less viable for future transplant use, especially for a larger child or adult recipient.
If you’re planning both delayed clamping and cord blood collection, discuss the timing with your delivery team in advance. Most providers will prioritize the baby’s immediate benefit from delayed clamping.
The Bottom Line on Value
Private cord blood banking is a low-probability insurance policy with significant limitations. The stored unit often can’t treat the diseases it’s marketed to protect against, the cell count may be insufficient for adult use, and the cost over two decades is substantial. Medical organizations do not recommend it as a routine practice.
For the small number of families with a known medical indication, private banking is a targeted, evidence-supported decision. For everyone else, donating to a public bank provides real value to patients in need while costing you nothing.